ஸ்ம் புத்தாண்தான் நிறுவனம் ஆன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Live COVID-19 updates: Brazil s COVID-19 death toll tops 215,000

Live COVID-19 updates: Brazil s COVID-19 death toll tops 215,000
shanghaisun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shanghaisun.com Daily Mail and Mail on Sunday newspapers.

Rio de janeiroEstado do rioDistrito federalSao pauloMashonaland eastAddis ababaInfrastructural development joel matizaAfrica centers for diseaseSao butantan institute onBrazil health regulatory agency anvisaHealth ministryAfrica centersDisease controlHealth regulatory agencySao paulo based butantan instituteHeilongjiang province

Brazil approves new batch of 4 8 million CoronaVac COVID-19 vaccines

Brazil approves new batch of 4 8 million CoronaVac COVID-19 vaccines
beijingnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beijingnews.net Daily Mail and Mail on Sunday newspapers.

United statesDistrito federalSinovac biotechOxford university astrazenecaButantan instituteSao butantan institute onXinhua brazil health regulatory agency anvisaHealth regulatory agencySao paulo based butantan instituteSouth americanFederal districtஒன்றுபட்டது மாநிலங்களில்திஸ்திரிதோ கூட்டாட்சியின்புத்தாண்தான் நிறுவனம்ஸ்ம் புத்தாண்தான் நிறுவனம் ஆன்ஸ்ம் பாலொ அடிப்படையிலானது புத்தாண்தான் நிறுவனம்

Brazil approves new batch of 4 8 million CoronaVac COVID-19 vaccines - World News

2021-01-23 02:36:08 GMT2021-01-23 10:36:08(Beijing Time) Xinhua English BRASILIA, Jan. 22 (Xinhua) Brazil s Health Regulatory Agency (Anvisa) unanimously approved on Friday the emergency use of another 4.8 million doses of the CoronaVac vaccine against COVID-19. The request was made by the Sao Paulo-based Butantan Institute on Monday, a day after Anvisa authorized the use of the first batch of 6 million doses of CoronaVac, which kicked off a countrywide COVID-19 vaccination process. The vaccines were developed by Chinese pharmaceutical firm Sinovac Biotech in partnership with the Butantan Institute. Anvisa said it considers CoronaVac a safe, quality and effective vaccine, noting that its application in the first week of immunization has not presented any problems.

United statesDistrito federalSinovac biotechOxford university astrazenecaButantan instituteSao butantan institute onXinhua brazil health regulatory agency anvisaHealth regulatory agencySao paulo based butantan instituteSouth americanFederal districtஒன்றுபட்டது மாநிலங்களில்திஸ்திரிதோ கூட்டாட்சியின்புத்தாண்தான் நிறுவனம்ஸ்ம் புத்தாண்தான் நிறுவனம் ஆன்ஸ்ம் பாலொ அடிப்படையிலானது புத்தாண்தான் நிறுவனம்